Live Breaking News & Updates on ஹான்ஸ் உல்ரிச் ஏங்கல்|Page 2
Stay updated with breaking news from ஹான்ஸ் உல்ரிச் ஏங்கல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cautionary note regarding forward-looking statements This presentation contains forward-looking statements. These statements are based on current estimates and projections of the Board of Executive Directors and currently available information. Forward-looking statements are not guarantees of the future developments and results outlined therein. These are dependent on a number of factors; they involve various risks and uncertainties; and they are based on assumptions that may not prove to be accurate. Such risk factors include those discussed in Opportunities and Risks on pages 158 to 166 of the BASF Report 2020. BASF does not assume any obligation to update the forward-looking statements contained in this presentation above and beyond the legal requirements. ....
(2019: €3.30 per share) Outlook 2021: (2020: €59.1 billion) EBIT before special items of between €4.1 billion and €5.0 billion (2020: €3.6 billion) In a challenging 2020 business year, BASF was able to close out the year on a strong note, said BASF s Chairman of the Board of Executive Directors, Dr. Martin Brudermüller, at the presentation of the BASF Report 2020. Income from operations (EBIT) before special items for the full year 2020 exceeded the company s forecast released in October and beat the analysts consensus. BASF had therefore released its preliminary figures already on January 20, 2021. We increased volumes in all regions in the fourth quarter of 2020, said Brudermüller. In Greater China, we continued to see double-digit volumes growth. Sales volumes rose in almost all segments in the final quarter of the year, he added. For some commodity product lines, such as isocyanates, BASF was also able to sig ....
Changes in the Board of Executive Directors of BASF Business & Financial News | December 17, 2020 Global Melanie Maas-Brunner appointed to the Board and succeeds Wayne T. Smith Redistribution of responsibilities effective February 1, 2021 and June 1, 2021 Ludwigshafen, Germany – December 17, 2020 – The Supervisory Board of BASF SE today appointed Dr. Melanie Maas-Brunner (52) as a member of the Board of Executive Directors effective February 1, 2021. Maas-Brunner has been with BASF since 1997 and has headed BASF’s Nutrition & Health division since 2017. In her new role as of February 1, 2021, she will also take over the position as Chief Technology Officer from Dr. Martin Brudermüller, Chairman of the Board of Executive Directors of BASF. She will assume responsibility for the three research divisions Advanced Materials & Systems Research, Bioscience Research, Process Research & Chemical Enginee ....